We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 442

Newsbytes

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 2 2014

The U.S. Patent and Trademark Office extends the deadline for applications under its Patents for Humanity Program, "which recognizes patent holders

Public watchdog calls on FDA to issue “revolving door” guidance

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 2 2014

Public Citizen recently called on the U.S. Food and Drug Administration (FDA) to take certain steps that would both prohibit the practice of advisory

Shire Pharmaceuticals settles FCA claims for $56.5 million

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 2 2014

Without admitting liability, Wayne, Pennsylvania-based Shire Pharmaceuticals LLC has entered a settlement agreement with the U.S. Department of

FDA contends Twitter not off limits for pharmaceutical cos.

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 2 2014

While the U.S. Food and Drug Administration (FDA) has extended the deadline for comments on its draft guidance for drug and medical device makers

Australian court finds human gene mutation to be patentable

  • Shook Hardy & Bacon LLP
  • -
  • Australia, USA
  • -
  • September 11 2014

A full panel of the Federal Court of Australia has upheld its earlier ruling that an isolated but naturally occurring nucleic acid, BRCA1, can be

Vaccine developer agrees to settle shareholder litigation

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • September 11 2014

A putative class action instituted by three shareholders against the nowbankrupt biotechnology company Biovest International, Inc., alleging

International funding agencies to support infectious disease research

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • September 11 2014

Under the Ecology and Evolution of Infectious Diseases program, three U.S. agenciesthe National Institutes of Health (NIH), National Science

FDA releases clinical trial action plan

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • September 11 2014

The U.S. Food and Drug Administration (FDA) has issued a 27-point action plan aimed at improving diversity in clinical trials. While the numbers of

“Purple Book” sets forth approved biologicals, will expand to biosimilars

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • September 11 2014

The U.S. Food and Drug Administration (FDA) has released lists of reference biological products regulated by the Center for Drug Evaluation and

KC Animal Health Corridor claims 56 percent of total worldwide sales

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • September 11 2014

An asset survey unveiled to animal health industry leaders during recent Kansas City (KC) Animal Health Corridor "homecoming" activities reportedly